Ultragenyx Pharma. Inc. (RARE)
| Sector: | Health Care |
| Super Investor Stats: | |
| Ownership count: | 0 |
| Ownership rank: | -- |
| % of all portfolios: | 0% |
| History | Portfolio Manager | Activity ▼ | Share change | % change to portfolio | |
| Q4 2021 | |||||
| ≡ | Lee Ainslie - Maverick Capital | Sell 100.00% | 5,861 | 0.01 | |
| Q3 2021 | |||||
| ≡ | Lee Ainslie - Maverick Capital | Reduce 42.38% | 4,311 | 0.01 | |
| Q2 2021 | |||||
| ≡ | Lee Ainslie - Maverick Capital | Reduce 8.96% | 1,001 | 0.00 | |
| Q1 2021 | |||||
| ≡ | Lee Ainslie - Maverick Capital | Buy | 11,173 | 0.01 | |
| Q2 2019 | |||||
| ≡ | Meridian Contrarian Fund | Sell 100.00% | 64,000 | 0.79 | |
| Q2 2018 | |||||
| ≡ | Leon Cooperman | Sell 100.00% | 88,500 | 0.17 | |
| Q1 2018 | |||||
| ≡ | Meridian Contrarian Fund | Buy | 64,000 | 0.53 | |
| ≡ | Leon Cooperman | Buy | 88,500 | 0.17 | |
* "Hold Price" is the last known price at which an investor still held a security. It is the closing price of the security as of the portfolio date (quarter end). This value is only provided when a security is owned by at least two investors. In the case of reporting dates being different, a weighted average price is calculated.